LR Health & Beauty Celebrates Its 40th Anniversary
The Social Commerce Company LR Health & Beauty is looking back on 40 years of company history this year. The company, which was founded in 1985, has developed into a global player in the direct selling industry in recent years.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250108836518/en/
LR Headquarters (Photo: Business Wire)
LR Health & Beauty has been setting innovative trends in the nutritional supplements and cosmetics sector for 40 years. The unique selling point: The products are sold by independent sales partners who earn an additional income by recommending products and setting up their own business. "LR stands for quality, innovation and a strong people business that offers an attractive business model to people who want more flexibility, more self-fulfilment and financial independence," explains CEO Dr. Andreas Laabs. "We are proud of the past years and thank our partners, customers and employees who have made this success possible."
Product solutions and business model at the cutting edge
The aim of the Ahlen-based direct selling company is to set new standards in the future, which will contribute to the further growth of the LR Group. LR Health & Beauty laid important foundations for this in 2024, both in terms of products and sales: in April, the Ahlen-based company launched the “LR Health Mission” intestinal metabolism treatment. The new decorative cosmetics line "LR ZEITGARD Signature" followed in September. Both launches will go down in LR history as two of the five most successful launches.
In terms of the business model, LR offers its sales partners a regulated, performance-based income if they meet the qualification criteria with the restructuring of the career plan in October 2024. This gives the LR partnership more security on the path to independence.
Four decades of success set standards for the future
In the course of its company history, LR has achieved numerous milestones. The company's most significant successes include the start of sales of nutritional supplements in 2000 and the success of the best-selling Aloe Vera Drinking Gel in 2002. In the same year, the new Ahlen headquarters on Kruppstraße were opened. Another highlight was the entry in the Guinness Book of Records (formation of the LR logo with 265 VW Polos; 2008) and the founding of the children's charity LR Global Kids Fund in 2009.
In 2015, the company was named the best European direct selling company of the year. The opening of the state-of-the-art aloe vera production facility followed in 2018, followed by the receipt of the "Business Award of the City of Ahlen" in 2019. With the introduction of the "Zeitgard Pro Cosmetic Device" in 2022, the intestinal metabolism treatment "LR Health Mission" in 2024 and the make-up line "ZEITGARD Signature", LR continues its success story.
One person who remembers these special events well is Managing Director Thomas Heursen. He started as an LR sales partner in 1990, quickly reached the career level of orgaleader and switched to the corporate side two years later. Thomas Heursen knows the LR business like no other and explains what LR's recipe for success is: "LR is always on the move and continues to develop without forgetting its roots. Close cooperation with our sales partners is important to us. We have successfully implemented this in recent years. With our product solutions and a business model that is in tune with the times, we are creating the ideal conditions for our partnership with LR to be as successful as possible."
LR Health & Beauty
The LR Group successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250108836518/en/
Contacts
LR Health & Beauty
Almut Kellermeyer
Head of Corporate Communication
Kruppstrasse 55
59227 Ahlen, Germany
Tel.: +49 2382 7813-106
E-mail: A.Kellermeyer@LRworld.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Coulson Aviation Announces Launch of Boeing 767 VLAT Program22.12.2025 14:03:00 CET | Press Release
Coulson Aviation USA has announced the launch of its Boeing 767 Very Large Airtanker (VLAT) program, marking a significant advancement in the evolution of aerial firefighting capability. The program is intended to provide a sustainable replacement for legacy VLAT platforms nearing the end of their operational service life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251222917730/en/ A cross-sectional view of Coulson Aviation’s Boeing 767 Very Large Airtanker (VLAT) illustrates the integration of the RADS retardant delivery system and the next generation of high-capacity, sustainable aerial firefighting design. The recent grounding of the MD11 and DC10 fleets has highlighted a structural challenge for firefighting agencies worldwide. As older widebody aircraft are retired, the industry faces a significant reduction in high-capacity, large-scale retardant delivery capability. Coulson’s 767 VLAT is being developed to address
Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 10:00:00 CET | Press Release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in
Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 10:00:00 CET | Press Release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration
Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 10:00:00 CET | Press Release
Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press Release
Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity. Pimicotinib, a colony stimulating factor-1 receptor (CSF-1R) inhibitor developed by Abbisko Therapeutics Co., Ltd., Shanghai, China, is the first Chemical Drug Class 1 approved in China for the treatment of TGCT. “We are continuing to deliver on our commitment to improving the lives of patients with rare tumors with this first-in-the-world regulatory approval of pimicotinib,” said Danny Bar-Zohar, CEO Healthcare and Member of the Executive Board of Merck. “This approval is a significant step forward in further strengthening our leadership in rare tumors, while offering patients the opportunity to change the course of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom